Efficacy of different beta-blockers in the treatment of long QT syndrome.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In LQTS, β-blocker therapy is effective in reducing the risk of cardiac events (syncope, aborted cardiac arrest, sudden cardiac death). Limited studies have compared the efficacy of different β-blockers.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Am. Coll. Cardiol.

Title: Journal of the American College of Cardiology

Publisher: Elsevier BV

ISSN (Electronic): 1558-3597

ISSN (Print): 0735-1097

Publication date (Electronic): Sep 30 2014

Volume: 64

Issue: 13

Affiliations

[1 ] Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York. Electronic address: abeer_abuzeitone@urmc.rochester.edu.

[2 ] Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York.

[3 ] Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York.

Article

Publisher Item ID: S0735-1097(14)05541-7

DOI: 10.1016/j.jacc.2014.05.068

PubMed ID: 25257637

SO-VID: c6056d90-7ad1-4198-b781-31162faf84ad

History

Keywords: atenolol,metoprolol,long QT syndrome,β-blocker therapy,nadolol,propranolol

Data availability:

Keywords: atenolol, metoprolol, long QT syndrome, β-blocker therapy, nadolol, propranolol

Efficacy of different beta-blockers in the treatment of long QT syndrome.

Read this article at

Abstract

Related collections

Efficacy of Communicating Science

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 71

Cited by 30